The available GLP-1 RA injectables are short or long-acting, and include [5,8-14]: Dulaglutide: Long-acting, once weekly Exenatide: Short-acting, twice a day Exenatide extended release: Long-acting, once weekly Liraglutide: Long-acting, once a day Lixisenatide: Short-acting, once a day Semaglutide: Long-acting, once weekly Combination of GLP-1 medications and exercise Non-medication management strategies for type 2 diabetes involve lifestyle modifications like diet and exercise
Theres a newer kind of weight loss drug thats typically given to people managing diabetes and is also sometimes given to people who want to lose weight: Some common brand names for these types of drugs are Ozempic, Wegovy, and Mounjaro
Now you may be wondering since all life requires a genetic code, how did it all start in the first place
"Even though it's not yet FDA-approved, some patients are aware of retatrutide and are already asking about it." Retatrutide Works Differently Than Other GLP-1s Retatrutide is different from FDA-approved GLP-1 medications like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)
As more people take semaglutide drugs, like Rybelsus, to manage their diabetes, increasing numbers of people may be at risk for this serious complication
These markets include both advanced healthcare systems and fastgrowing regions where price and compliance matter most